55 results on '"Ellemunter, H."'
Search Results
2. 293 Impact of elexacaftor-tezacaftor-ivacaftor on lung function, nutritional status, pulmonary exacerbation, and sweat chloride in people with cystic fibrosis: real-world evidence from German Cystic Fibrosis Registry
3. EPS9.02 Pseudomonas aeruginosa in sputum cultures of patients with cystic fibrosis before and during one year of elexacaftor/tezacaftor/ivacaftor
4. EPS2.07 The Brief Resilience Scale (BRS) as a possible routine assessment instrument for patients with cystic fibrosis: predictive power in psychological symptoms and quality of life
5. Mukoviszidose (Cystische Fibrose): Ernährung und exokrine Pankreasinsuffizienz
6. Diagnose der Mukoviszidose (S2)
7. EPS2.05 Arm circumference and skinfolds vs. body mass index: a single-centre experience over two decades
8. WS11.3 Predicting anxiety, depression and affectivity in adults living with cystic fibrosis: the role of psychological resilience and self-compassion over a 2-year period
9. ePS4.04 Skinfold measurements for nutritional assessment: a longitudinal single centre analysis
10. ePS5.06 Assessment of patient satisfaction as a means of quality development and patient participation in German cystic fibrosis centres
11. P399 High utilisation of an ongoing group education programme for parents as part of routine care
12. P065 Gradually improving health status of adults with cystic fibrosis from 2008 to 2017
13. P452 Predicting psychological well-being and symptoms in adults living with cystic fibrosis: the role of self-compassion and psychological resilience
14. IPD2.04 Long-term effects of ivacaftor in patients with G551D mutation and mild lung disease
15. P271 Malignant diseases in patients treated at the CF Centre Innsbruck
16. S3-Leitlinie: Lungenerkrankung bei Mukoviszidose – Modul 2: Diagnostik und Therapie bei der chronischen Infektion mit Pseudomonas aeruginosa
17. 397 The course of anxiety and depression in adult CF patients – preliminary results of a two-year experience with Mental Health Screening (MHS)
18. 395 Challenges in implementing Mental Health Screening (MHS) – a single centre experience
19. 182 Lung clearance index to detect the efficacy of aztreonam lysine inhalation in CF patients with near normal spirometry – an observational proof-of-concept study
20. WS17.4 Fecal calprotectin and its relation to disease parameters – a longitudinal analysis over 12 years
21. 288 Resilience, intolerance of uncertainty, and CF patients’ quality of life
22. WS09.4 The role of resilience in quality of life of adult patients with cystic fibrosis (CF)
23. Erratum to “Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis”
24. Die Anfänge der Subdisziplin „Pädiatrische Gastroenterologie“ in Österreich
25. 311 Do quality of life responses signal severe loss of lung function?
26. 298 Delivery of CF care through the patients' eyes: Repeated surveys of patients' experiences at Innsbruck CF centre
27. WS19.9 A prospective multicenter study to dissect Staphylococcus aureus-colonization from infection in cystic fibrosis patients
28. 312 The course of perceived treatment burden in adolescent and adult CF patients
29. Strukturierte Versorgung von Mukoviszidosepatienten und ihren Angehörigen in einem ISO-zertifizierten Behandlungszentrum
30. 361 The influence of experiential avoidance on depression, anxiety and life quality in adult cystic fibrosis (CF) patients
31. PEDIATRIC LIVER TRANSPLANTATION - THE INNSBRUCK EXPERIENCE
32. The impact of psychosocial and socioeconomic factors on health status in children with cystic fibrosis
33. CF care through the patient's eyes – development of a disease specific questionnaire measuring patient satisfaction with CF services
34. The significance of Experiential Avoidance concerning anxiety and depression in parents of CF children
35. P0458 FECAL TISSUE TRANSGLUTAMINASE ANTIBODY (FTTGA) CONCENTRATIONS CORRECTLY IDENTIFY PATIENTS WITH CELIAC DISEASE
36. P0458 FECAL TISSUE TRANSGLUTAMINASE ANTIBODY (FTTGA) CONCENTRATIONS CORRECTLY IDENTIFY PATIENTS WITH CELIAC DISEASE
37. Bildgebende Diagnostik nach Lebertransplantation bei Kindern: Postoperative Anatomie und Komplikationen
38. Increased tacrolimus levels during diarrhea
39. Elevated tacrolimus trough levels in association with mycophenolate mofetil-induced diarrhea: A case report
40. Rotavirus infection as cause of tacrolimus elevation in solid‐organ‐transplanted children
41. Distribution of Rotavirus VP4 Genotypes and VP7 Serotypes among Nonhospitalized and Hospitalized Patients with Gastroenteritis and Patients with Nosocomially Acquired Gastroenteritis in Austria
42. Sydenham Chorea or Primary Antiphospholipid Syndrome?
43. Congenital sodium diarrhea
44. Unusual association of the DRB4 null allele, DRB4*0103102N, with HLA DRB1*0402 in a sample of Austrian patients
45. Bilateral nephrectomy, peritoneal dialysis and subsequent cadaveric renal transplantation for treatment of renal failure due to polycystic kidney disease requiring continuous ventilation
46. CONGENITAL Na+ - DIARRHEA IS AN AUTOSOMAL RECESSIVE DEFECT OF INTESTINAL Na+ - TRANSPORT
47. Chorea as the Presenting Clinical Feature of Primary Antiphospholipid Syndrome in Childhood
48. Intraosseous lines in preterm and full term neonates
49. Detection of 100% of the CFTR mutations in 63 CF families from Tyrol
50. Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.